- Home
- SBFG vs MYO Comparison
SBFG vs MYO Comparison
Compare SBFG & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFG
- MYO
- Stock Information
- Founded
- SBFG 1983
- MYO 2004
- Country
- SBFG United States
- MYO United States
- Employees
- SBFG N/A
- MYO N/A
- Industry
- SBFG Major Banks
- MYO Industrial Specialties
- Sector
- SBFG Finance
- MYO Health Care
- Exchange
- SBFG Nasdaq
- MYO Nasdaq
- Market Cap
- SBFG 128.3M
- MYO 153.0M
- IPO Year
- SBFG N/A
- MYO 2017
- Fundamental
- Price
- SBFG $19.60
- MYO $3.22
- Analyst Decision
- SBFG
- MYO Strong Buy
- Analyst Count
- SBFG 0
- MYO 4
- Target Price
- SBFG N/A
- MYO $9.50
- AVG Volume (30 Days)
- SBFG 23.5K
- MYO 442.3K
- Earning Date
- SBFG 05-01-2025
- MYO 05-07-2025
- Dividend Yield
- SBFG 2.96%
- MYO N/A
- EPS Growth
- SBFG N/A
- MYO N/A
- EPS
- SBFG 1.70
- MYO N/A
- Revenue
- SBFG $58,812,000.00
- MYO $38,628,624.00
- Revenue This Year
- SBFG N/A
- MYO $57.44
- Revenue Next Year
- SBFG N/A
- MYO $21.76
- P/E Ratio
- SBFG $11.51
- MYO N/A
- Revenue Growth
- SBFG 4.73
- MYO 97.60
- 52 Week Low
- SBFG $13.01
- MYO $2.76
- 52 Week High
- SBFG $24.48
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- SBFG 52.02
- MYO 26.65
- Support Level
- SBFG $18.53
- MYO $4.65
- Resistance Level
- SBFG $19.89
- MYO $4.87
- Average True Range (ATR)
- SBFG 0.77
- MYO 0.28
- MACD
- SBFG 0.09
- MYO -0.11
- Stochastic Oscillator
- SBFG 72.89
- MYO 3.28
About SBFG SB Financial Group Inc.
SB Financial Group Inc that provides a range of community banking services, including commercial and consumer lending, personal and business banking, treasury management and merchant services, personal wealth management and brokerage services, and other financial services to individuals, businesses, and municipalities. It operates in single segment which is Banking.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).